樊代明院士:光吸引人眼球的媒体,不是好媒体

2016-06-20 MedSci MedSci原创

樊代明院士是我国著名的医学家、科学家、也是文学家、哲学家和教育学家。在第十二届全国癌症康复与姑息医学大会,带来了精彩的演讲——医学与科学。详见:樊代明院士论医学与科学,说出了所有医生的心里话 樊代明院士 梅斯医学作为媒体合作单位,有幸采访到了樊代明院士,请教了医学与哲学及中国目前中医现状问题。樊代明院士同时对记者和媒体提出了真切的要求。 医学与哲学

樊代明院士是我国著名的医学家、科学家、也是文学家、哲学家和教育学家。在第十二届全国癌症康复与姑息医学大会,带来了精彩的演讲——医学与科学。详见:樊代明院士论医学与科学,说出了所有医生的心里话


樊代明院士


梅斯医学作为媒体合作单位,有幸采访到了樊代明院士,请教了医学与哲学及中国目前中医现状问题。樊代明院士同时对记者和媒体提出了真切的要求。

医学与哲学

樊代明院士指出《易传》中写到:形而上者为道(道可理解为哲学),形而下者为器(器可理解为科学),而医生是形而中者为医。医生上要通道,用哲学的道理指导自己,下要懂科学,用科学作为支撑。所以医生面临的情况是,因素无限多,变化无穷大,相当于一种混沌状态。

想要当好医生,必须要有三个整合,一是串联式的整合,即线性整合,将很多相关因素串成一条线;第二是并联式的整合,即将多个线形成一块板面;最高形式的整合是交联式的整合,即将若干个板形成一个整体。所以分析事物,串联式的关联只需要逻辑性关系;不同事物之间的关系叫抽象分析,抽象分析根据个体角度不一样,水平不一样,可能结果不一样。同一个患者,一个医生看可能是这种疾病,另一个医生可能得出不同的结论。最高水平是形象思维,即对象,对象并不是局部的,而是整体的看待。不仅包括一个个体的物质,还包括该个体的所有因素。比如说天气预报的预测,开始是分子层面的整合,可能得出今晚不下雨的结果。而一个农民,从外地回来,预测今天晚上会下雨,结果真的下雨了。老农民觉得空气很沉,很闷,沉和闷就代表了所有的因素,是对经验和证据的总结。很多人到不了形象思维,连抽象思维都很难达到。

中医发展的契机

樊代明院士在演讲中提到,中医也有自己的科学。科学研究的是物质,所以是物质不灭论,医学研究是生命,回答生死有期。西医是研究物质的,与科学很相似,所以我们认为西医是科学的;而中医是研究生命的功能,不太像科学,所以人们总说中医不科学。但其实中医和西医都是从不同的角度研究生命。西医和中医都不等于科学,但都属于医学。

樊代明院士对中医现状的总结如下:

第一、在人类历史上,中医从未像现在这般受到重视,有如此高的社会地位。

第二、中医药学是现在唯一能和西医媲美的第二大医学体系。

第三、由于中医解决了很多现在西医无法解决的重大问题,所以显示出了不可替代的作用。

第四、中医必将成为未来医学发展时代,即整合医学时代的主要贡献者。

未来要做好以上事情,必须依靠整合医学。

在演讲中,樊代明院士对现在医生的处境发表了自己的看法——当好医生真的很难。樊代明院士多次强调医生的收入应该是社会平均工资的三到四倍,而不是要依靠灰色收入维持生活。樊代明院士提出整合医学观点论的另一原因是,希望国家能从上层到下层都认识到医学要比科学重要,最起码,我们要像尊重科学家一样尊重医生。医学才是人类最崇高的事业!所有的科学发展都是为医学服务的,所有科学发展的终极目标都是为了让人活得长一点,活得好一点。所以,一定要尊重我们的医生,不能杀害医生。

对于多年来媒体对医生和医学的误导,樊代明院士更是语重心长的对梅斯小编说,做媒体一定要有良心,对某一件事情的报道,要使得医生更加理解患者,患者更加理解医生,只是为了吸引眼球的不是好记者!

感谢樊代明院士的谆谆教诲,希望我们的大众媒体朋友都能谨记这样一份简单的要求,樊代明院士还指出,作为一个记者一定要多读书。我想,这样不仅是为了做出更加公正和高质量的报道,也是为了陶冶情操,培养道德。

医患关系是一个复杂的关系,片面报道甚至虚假报道,无疑是对社会造成了巨大的危害。不得不承认,我们医学类公众号是偏向医护群体的,不仅是因为我们深知医护工作的不易,医疗工作的复杂性,也是为了同广大大众媒体作斗争。但过度渲染,不考虑患者的处境,也不过是激化了医患矛盾,并不是可取的方式。如何通过一篇报道,对一件事情客观真实的描述来增加医患之间的理解是广大媒体和记者朋友需要不断探索和前进的正确道路。

一句老话:做人要有良心,放之四海皆准,但对传播力极强的各类媒体,此句话显得更加沉重。希望各位媒体朋友谨记良言,共同为促进中国医疗发展和医患关系的稳定作出自己的一份贡献。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1684043, encodeId=86dd168404364, content=<a href='/topic/show?id=a9fee2770d0' target=_blank style='color:#2F92EE;'>#眼球#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72770, encryptionId=a9fee2770d0, topicName=眼球)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a38928025675, createdName=刘阔, createdTime=Thu Feb 09 19:08:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91003, encodeId=a3ee91003f1, content=说的没错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Fri Jun 24 10:30:00 CST 2016, time=2016-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90854, encodeId=4bdb908542d, content=对, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160521/IMG574005ECB12D94444.jpg, createdBy=b3b01657609, createdName=风中野草, createdTime=Wed Jun 22 23:56:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568793, encodeId=6c101568e93e2, content=<a href='/topic/show?id=967c62945b4' target=_blank style='color:#2F92EE;'>#樊代明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62945, encryptionId=967c62945b4, topicName=樊代明)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1015444723, createdName=珙桐, createdTime=Wed Jun 22 09:08:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90691, encodeId=23219069124, content=非常对, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0921674448, createdName=gyczyxy, createdTime=Tue Jun 21 08:54:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90670, encodeId=266d906e0a6, content=此话不假, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Mon Jun 20 21:58:00 CST 2016, time=2016-06-20, status=1, ipAttribution=)]
    2017-02-09 刘阔
  2. [GetPortalCommentsPageByObjectIdResponse(id=1684043, encodeId=86dd168404364, content=<a href='/topic/show?id=a9fee2770d0' target=_blank style='color:#2F92EE;'>#眼球#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72770, encryptionId=a9fee2770d0, topicName=眼球)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a38928025675, createdName=刘阔, createdTime=Thu Feb 09 19:08:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91003, encodeId=a3ee91003f1, content=说的没错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Fri Jun 24 10:30:00 CST 2016, time=2016-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90854, encodeId=4bdb908542d, content=对, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160521/IMG574005ECB12D94444.jpg, createdBy=b3b01657609, createdName=风中野草, createdTime=Wed Jun 22 23:56:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568793, encodeId=6c101568e93e2, content=<a href='/topic/show?id=967c62945b4' target=_blank style='color:#2F92EE;'>#樊代明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62945, encryptionId=967c62945b4, topicName=樊代明)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1015444723, createdName=珙桐, createdTime=Wed Jun 22 09:08:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90691, encodeId=23219069124, content=非常对, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0921674448, createdName=gyczyxy, createdTime=Tue Jun 21 08:54:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90670, encodeId=266d906e0a6, content=此话不假, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Mon Jun 20 21:58:00 CST 2016, time=2016-06-20, status=1, ipAttribution=)]
    2016-06-24 zybear

    说的没错!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1684043, encodeId=86dd168404364, content=<a href='/topic/show?id=a9fee2770d0' target=_blank style='color:#2F92EE;'>#眼球#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72770, encryptionId=a9fee2770d0, topicName=眼球)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a38928025675, createdName=刘阔, createdTime=Thu Feb 09 19:08:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91003, encodeId=a3ee91003f1, content=说的没错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Fri Jun 24 10:30:00 CST 2016, time=2016-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90854, encodeId=4bdb908542d, content=对, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160521/IMG574005ECB12D94444.jpg, createdBy=b3b01657609, createdName=风中野草, createdTime=Wed Jun 22 23:56:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568793, encodeId=6c101568e93e2, content=<a href='/topic/show?id=967c62945b4' target=_blank style='color:#2F92EE;'>#樊代明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62945, encryptionId=967c62945b4, topicName=樊代明)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1015444723, createdName=珙桐, createdTime=Wed Jun 22 09:08:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90691, encodeId=23219069124, content=非常对, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0921674448, createdName=gyczyxy, createdTime=Tue Jun 21 08:54:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90670, encodeId=266d906e0a6, content=此话不假, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Mon Jun 20 21:58:00 CST 2016, time=2016-06-20, status=1, ipAttribution=)]
    2016-06-22 风中野草

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1684043, encodeId=86dd168404364, content=<a href='/topic/show?id=a9fee2770d0' target=_blank style='color:#2F92EE;'>#眼球#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72770, encryptionId=a9fee2770d0, topicName=眼球)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a38928025675, createdName=刘阔, createdTime=Thu Feb 09 19:08:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91003, encodeId=a3ee91003f1, content=说的没错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Fri Jun 24 10:30:00 CST 2016, time=2016-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90854, encodeId=4bdb908542d, content=对, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160521/IMG574005ECB12D94444.jpg, createdBy=b3b01657609, createdName=风中野草, createdTime=Wed Jun 22 23:56:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568793, encodeId=6c101568e93e2, content=<a href='/topic/show?id=967c62945b4' target=_blank style='color:#2F92EE;'>#樊代明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62945, encryptionId=967c62945b4, topicName=樊代明)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1015444723, createdName=珙桐, createdTime=Wed Jun 22 09:08:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90691, encodeId=23219069124, content=非常对, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0921674448, createdName=gyczyxy, createdTime=Tue Jun 21 08:54:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90670, encodeId=266d906e0a6, content=此话不假, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Mon Jun 20 21:58:00 CST 2016, time=2016-06-20, status=1, ipAttribution=)]
    2016-06-22 珙桐
  5. [GetPortalCommentsPageByObjectIdResponse(id=1684043, encodeId=86dd168404364, content=<a href='/topic/show?id=a9fee2770d0' target=_blank style='color:#2F92EE;'>#眼球#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72770, encryptionId=a9fee2770d0, topicName=眼球)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a38928025675, createdName=刘阔, createdTime=Thu Feb 09 19:08:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91003, encodeId=a3ee91003f1, content=说的没错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Fri Jun 24 10:30:00 CST 2016, time=2016-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90854, encodeId=4bdb908542d, content=对, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160521/IMG574005ECB12D94444.jpg, createdBy=b3b01657609, createdName=风中野草, createdTime=Wed Jun 22 23:56:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568793, encodeId=6c101568e93e2, content=<a href='/topic/show?id=967c62945b4' target=_blank style='color:#2F92EE;'>#樊代明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62945, encryptionId=967c62945b4, topicName=樊代明)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1015444723, createdName=珙桐, createdTime=Wed Jun 22 09:08:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90691, encodeId=23219069124, content=非常对, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0921674448, createdName=gyczyxy, createdTime=Tue Jun 21 08:54:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90670, encodeId=266d906e0a6, content=此话不假, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Mon Jun 20 21:58:00 CST 2016, time=2016-06-20, status=1, ipAttribution=)]
    2016-06-21 gyczyxy

    非常对

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1684043, encodeId=86dd168404364, content=<a href='/topic/show?id=a9fee2770d0' target=_blank style='color:#2F92EE;'>#眼球#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72770, encryptionId=a9fee2770d0, topicName=眼球)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a38928025675, createdName=刘阔, createdTime=Thu Feb 09 19:08:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=91003, encodeId=a3ee91003f1, content=说的没错!, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Fri Jun 24 10:30:00 CST 2016, time=2016-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90854, encodeId=4bdb908542d, content=对, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160521/IMG574005ECB12D94444.jpg, createdBy=b3b01657609, createdName=风中野草, createdTime=Wed Jun 22 23:56:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568793, encodeId=6c101568e93e2, content=<a href='/topic/show?id=967c62945b4' target=_blank style='color:#2F92EE;'>#樊代明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62945, encryptionId=967c62945b4, topicName=樊代明)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c1015444723, createdName=珙桐, createdTime=Wed Jun 22 09:08:00 CST 2016, time=2016-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90691, encodeId=23219069124, content=非常对, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d0921674448, createdName=gyczyxy, createdTime=Tue Jun 21 08:54:00 CST 2016, time=2016-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90670, encodeId=266d906e0a6, content=此话不假, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2SEXGDldsNfP4rKvY7vJmaHcyvLXicuyaCTJtVOkX3jvd6DwNMD88hDjJwsU7MnUH6zeqC4zt3yGV/0, createdBy=4e701628585, createdName=flyingzyx, createdTime=Mon Jun 20 21:58:00 CST 2016, time=2016-06-20, status=1, ipAttribution=)]
    2016-06-20 flyingzyx

    此话不假

    0

相关资讯

樊代明指出整合医学更利于治病救人

  “以细分学科为主的发展方式确实推动了现代医学的进步,但过度分科也伤害了医学,不利于治病救人。”12月17日,中国工程院副院长、第四军医大学校长樊代明在首届整体整合医学高峰论坛上指出。   在此次由国家心血管病中心和阜外心血管病医院主办的论坛上,多位医学领域专家针对当下医学过度分科会导致哪些问题、“对症治疗”却为何看不好病人、整合医学的发展面临的诸多困难等社会关切问题阐述了自己的观点。   

樊代明院士获首届法国医科院塞维雅奖

  6月13日,法国医学科学院雅克·刚教授受弗朗西斯院长委托专程来华,授予中国工程院副院长、著名消化病学专家樊代明院士法国医学科学院塞维雅奖。樊代明是首位获得这一殊荣的中国科学家。   “塞维雅奖2013年设立,用于表彰在中国医学科学技术及管理领域有重要发现发明、成绩显著的科学家以及为中法医学科学交流作出杰出贡献的学者。”雅克·刚说。该奖项由法

樊代明院士撰文:加减乘除话医改

人类发展史就是人类同自然界的斗争史,也是人类同伤病的斗争史。无论你是什么人种,无论你生活在地球的哪个位置,也无论你经受了什么样的社会制度、宗教信仰,在你体内暗藏的遗传基因都经历了人类发展的三个阶段。最先是缺吃少穿,意即衣食,这个阶段历经了很多很多年,人类一直在为解决温饱,可以说是在为“能活(得下来)”而奋斗。然后是缺房少车,意指住行,这个问题解决得快一些,其实是在解决生存或生活的便利,可以说是

医学是科学吗?

医学远比科学复杂医学不是纯粹的科学,也不是单纯的哲学,医学充满了科学和哲学,还涵盖有社会学、人类学、艺术学、心理学等。因而,我们不能笼统地用科学的范畴来解释医学,也不可以简单地用科学的标准来要求医学。医学比科学起源早。科学一词的出现才1000多年,而医学已有数千年甚至更久的历史。将医学视为科学的一个分支或隶属于科学、服从于科学,甚至把医学视为医学科学的简称,看来是不恰当的,甚至有失偏颇。医学研究的

樊代明院士论医学与科学,说出了所有医生的心里话

导语:当医生比当科学家难得多,医学才是人类最崇高的事业,人类科学发展的终极目的都是为人类服务,为了让人能活得长一些,活的久一些。所以,有什么理由不尊重医生? 背景介绍: 整合医学 樊代明院士 樊代明院士整合医学论简介:事物发展多数都表现为“分久必合,合久必分”之现象,通常都按照“螺旋上升,波浪前行”之方式。现代医学的发展已经将医学分的很细